assigned only after discharge, care teams may choose to design prospective programs that apply to the wider group of patients with actively managed HF, thus globally enhancing HF disease management.
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1.

Administrative Codes for Capturing In-Hospital Cardiac Arrest
Data collection and feedback registries have advanced our understanding of care strategies and outcomes for in-hospital cardiac arrest.
1,2 Several investigations have attempted to broaden understanding of outcomes among nonregistry hospitals using billing codes for cardiac arrest or cardiopulmonary resuscitation to identify cases of in-hospital cardiac arrest. [3] [4] [5] However, the validity of using administrative billing data to study in-hospital cardiac arrest remains unknown. We sought to assess whether use of administrative data to identify cases of in-hospital cardiac arrest in Medicare claims data is reliable when compared with carefully reviewed data submitted to a national registry for in-hospital cardiac arrest.
Methods | Using data from Get With the GuidelinesResuscitation (GWTG-Resuscitation; American Heart Association) (a large prospective registry of confirmed cases of inhospital cardiac arrest) linked to data from fee-for-service Medicare claims, 6 we evaluated the sensitivity of administra- or procedure codes for cardiopulmonary resuscitation (ICD-9-CM codes 99.60, 99.63) or defibrillation (ICD-9-CM code 99.62). Furthermore, among GWTG-Resuscitation hospitals with 10 or more cases, we examined hospital-level variation in rates of administrative capture for cardiac arrest with each strategy. We also described this variation using median odds ratio, which quantifies the average site-level variation in capture rates for 2 identical patients. Finally, we compared rates of survival to discharge with each strategy with the observed survival rate in the reference GWTG-Resuscitation cohort.
Results | Of 56 678 patients with an in-hospital cardiac arrest in GWTG-Resuscitation, 26 547 (46.8%) were identified using diagnosis codes for cardiac arrest and 21 096 (37.2%) with procedure codes for cardiopulmonary resuscitation or defibrillation. A total of 11 882 (21.0%) had both a diagnosis and procedure code, and 20 917 (36.9%) were not identified with any billing data (Table) . There was substantial hospital-level variation in identifying cases of in-hospital cardiac arrest using Medicare administrative data ( Figure) , with a median odds ratio of 1.63 (95% CI, 1.57-1.70) using diagnosis codes and 2.92 (95% CI, 2.71-3.18) using procedure codes. Use of diagnosis or procedure codes to identify patients with an in-hospital cardiac arrest had significant implications for survival outcomes. Compared with an 18.7% rate of survival to hospital discharge in the reference GWTG-Resuscitation cohort, those identified as having an in-hospital cardiac arrest using ICD-9-CM diagnosis codes had a survival rate of 28.4%, whereas those identified using ICD-9-CM procedure codes had survival rates of 15.7% and those not identified at all had survival rates of 12.0% 
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(Two-sided P < .001 for all, compared with their complement from the GWTG-Resuscitation) (Table) .
Discussion | In this study of 56 678 patients with confirmed inhospital cardiac arrest, we identified several key limitations of using administrative data for cardiac arrest research. Most studies have used a diagnosis or procedure code alone to identify cases of in-hospital cardiac arrest. However, we found that most confirmed cases in a national registry would not be captured using either administrative data strategy. Furthermore, survival rates using administrative data to identify cases from the same reference population varied markedly and were 52% higher (28.4% vs 18.7%) when using diagnosis codes alone to identify in-hospital cardiac arrest. Finally, there was large hospital variation in documenting diagnosis or procedure codes for patients with in-hospital cardiac arrest, which would have consequences for using administrative data to examine hospital-level variation in cardiac arrest incidence or survival, or for conducting single-center studies to validate this administrative approach. Our study highlights the collective challenges of using administrative billing data to conduct research on in-hospital cardiac arrest.
Our study was limited in that it did not evaluate the positive predictive value of cardiac arrest cases identified using administrative codes, or assess whether GWTG-Resuscitation captures all cardiac arrest cases in hospitals. Deidentification of data within GWTG-Resuscitation Medicare files precluded such analyses, but these additional issues present important areas of research for future studies.
Postmarketing Adverse Events Related to the CardioMEMS HF System
The CardioMEMS HF System (Abbott), a wireless pulmonary artery (PA) sensor, was demonstrated to safely reduce heart failure (HF) hospitalizations in the randomized, singleblinded study of 550 patients, CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in New York Heart Association Class III Heart Failure Patients (CHAMPION) trial, 1 
